Ensayo clínico en reclutamiento = ; Ensayos clínico en curso = ; Financiado por un miembro del IRDiRC =

Ensayo(s) clínico(s) nacional(es)

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

A clinical study of immune globulin subcutaneous (human) (IGSC), 20% for the evaluation of efficacy, safety, and pharmacokinetics in subjects with primary immunodeficiency diseases - BE

Institution: Information not provided - BE

Para más detalles

FRANCIA

NORMANDIE
CAEN

A Randomized, Cross-over Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL According to the Delivery Device: Injections Using Pump or Rapid Push (Phase IV)

CHU de Caen - Hôpital de la Côte de Nacre

Service de Médecine interne

Para más detalles

REINO UNIDO (EL)

Greater Manchester
ADDRESS: NOT PROVIDED - UK

A clinical study of immune globulin subcutaneous (human) (igsc), 20% for the evaluation of efficacy, safety, and pharmacokinetics in subjects with primary immunodeficiency diseases - UK (Completed)

Institution: Information not provided - UK

Para más detalles